LeMaitre Vascular (LMAT) said late Monday it has priced a $150 million private offering of 2.50% convertible senior notes due 2030.
LeMaitre has also granted initial purchasers of the notes a 13-day option to acquire up to $22.5 million in additional notes.
Net proceeds, estimated to be about $145.9 million to $167.8 million, will be used for working capital and other general corporate purposes, the company said.
The initial conversion rate for the notes is 8.3521 shares of common stock per $1,000 of principal, or $119.73 per share, a premium of about 30% over Monday's closing price of $92.10 per share.
Settlement of the notes is expected to occur on Dec. 19, subject to customary closing conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.